Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed

Overview of attention for article published in Journal of Immune Based Therapies and Vaccines, May 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

policy: 1 policy source

patent: 5 patents

Citations

dimensions_citation: 92 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Compositions useful in treatment of spinal muscular atrophy

Grant US-11578341-B2

United States of America

HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2

Application EP-3868405-A1

European Patent Office

HUMAN MONOCLONAL ANTIBODIES AGAINST BACILLUSANTHRACIS PROTECTIVE ANTIGEN

Grant EP-1633785-B1

European Patent Office

NEUTRALIZING HUMAN ANTIBODIES TO ANTHRAXTOXIN

Application WO-2005081749-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.